Anti-prostatic activity of bifluranol, a fluorinated bibenzyl.
1 Endocrine and anti-fertility studies were carried out on a fluorinated bibenzyl, bifluranol, in rats and mice. 2 A potent anti-prostatic activity of bifluranol was shown to be comparable to diethylstilboestrol (DES). In contrast, its oestrogenic potency by the oral route was about eight times less than that of DES. 3 In comparative short and long-term anti-androgenic and fertility studies in rats and in studies on sexual potency and reproductive performance in male mice, bifluranol given orally was shown to produce fully reversible suppression of accessory sexual structures without impairment of spermatogenesis and fertility. In contrast, DES administered in the same dose reduced spermatogenesis as well as accessory sexual glands. 4 Bifluranol lowered serum luteinising hormone (LH) levels without affecting follicle stimulating hormone (FSH). Under similar conditions DES reduces both LH and FSH levels. Since bifluranol does not antagonize androgen-induced stimulation of the prostate in castrated rats, its anti-prostatic effect is interpreted as a negative, hormonostatic feedback activity, mediated through a selective inhibition of LH secretion.
D000726:Androgen Antagonists; D000818:Animals; D000988:Antispermatogenic Agents; D001835:Body Weight / Q000187:drug effects; D002369:Castration; D004968:Estrogens, Non-Steroidal; D005298:Fertility / Q000187:drug effects; D005464:Fluorobenzenes; D006062:Gonadotropins / Q000378:metabolism; D006589:Hexestrol / Q000031:analogs & derivatives* / Q000494:pharmacology; D008297:Male; D051379:Mice; D011467:Prostate / Q000187:drug effects*; D051381:Rats; D012726:Sexual Behavior, Animal / Q000187:drug effects; D045165:Testosterone Congeners
D000726:Androgen Antagonists; D000988:Antispermatogenic Agents; D004968:Estrogens, Non-Steroidal; D005464:Fluorobenzenes; D006062:Gonadotropins; D045165:Testosterone Congeners; D006589:Hexestrol; C017070:bifluranol